NCT05812209已完成不适用
Stellate Ganglion Block to Treat Long COVID-19 Syndrome, A 41 Patient Retrospective Cohort Study
Metamorphosis LTD1 个研究点 分布在 1 个国家目标入组 41 人开始时间: 2022年9月1日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 41
- 试验地点
- 1
- 主要终点
- Symptom Response
研究概览
简要总结
An assessment of the effectiveness of Stellate Ganglion Block in alleviating symptoms of Long COVID-19.
详细描述
We evaluated the treatment results of 41 patients (18 male and 23 female) aged between 18 and 89, who received Stellate Ganglion Block (SGB) with Ultrasound guidance for Long COVID-19 Syndrome. The patients were from the United States and received treatment at our Colorado clinics during the period of September to December 2022.Those who responded to our post-procedure follow-up calls were included in the study population.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Retrospective
入排标准
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •People who scheduled themselves for a SGB in our clinics in Colorado.
排除标准
- •Stellate Ganglion Block Contraindications
结局指标
主要结局
Symptom Response
时间窗: 3 months
Evaluation of the symptoms response to the Stellate Ganglion Block
次要结局
未报告次要终点
研究者
Lisa Pearson
Dr. Lisa Pearson, CRNA, NSPMc
Metamorphosis LTD
研究点 (1)
Loading locations...
相似试验
终止
1 期
Stellate Ganglion Blockade in Corona Virus 2019 (COVID-19) Positive PatientsCOVID 19ARDSNCT04445337University of Nebraska1
已完成
2 期
Stellate Ganglion Block for COVID-induced ParosmiaCOVID-19-Induced ParosmiaNCT06253806Washington University School of Medicine48
已完成
1 期
Stellate Ganglion Block for COVID-19-Induced Olfactory DysfunctionHyposmiaParosmiaOlfactory DisorderAnosmiaNCT05445921Washington University School of Medicine20
招募中
不适用
UDCA in the Treatment of COVID-19 Infection and Its Clinical Prognosis in Patients With Autoimmune Liver DiseaseCOVID-19 InfectionNCT05812612Beijing Ditan Hospital2,000
已完成
不适用
Vagus Nerve Stimulation as Treatment for Long CovidLong COVIDChronic Fatigue SyndromeNCT05608629Icahn School of Medicine at Mount Sinai17